Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 3.

Bersano, Anna; Guey, Stephanie; Bedini, Gloria; Nava, Sara; Hervé, Dominique; Vajkoczy, Peter; Tatlisumak, Turgut; Sareela, Marika; van der Zwan, Albert; Klijn, Catharina J M; Braun, Kees P J; Kronenburg, Annick; Acerbi, Francesco; Brown, Martin M; Calviere, Lionel; Cordonnier, Charlotte; Henon, Hilde; Thines, Laurent; Khan, Nadia; Czabanka, M; Kraemer, Markus; Simister, Robert; Prontera, Paolo; Tournier-Lasserve, E; Parati, Eugenio; European Moyamoya Disease Initiative (2016). Research progresses in understanding the pathophysiology of moyamoya disease. Cerebrovascular Diseases, 41(3-4):105-118.

Blaes, J; Weiler, M; Sahm, F; Hentschel, B; Osswald, M; Czabanka, M; Thomé, C M; Schliesser, M G; Pusch, S; Luger, S; Winkler, F; Radbruch, A; Jugold, M; Simon, M; Steinbach, J P; Schackert, G; Tatagiba, M; Westphal, M; Tonn, J C; Gramatzki, D; Pietsch, T; Hartmann, C; Glimm, H; Vajkoczy, P; von Deimling, A; Platten, M; Weller, M; Wick, W (2014). NDRG1 prognosticates the natural course of disease in WHO grade II glioma. Journal of Neuro-Oncology, 117(1):25-32.

Weiler, M; Blaes, J; Pusch, S; Sahm, F; Czabanka, M; Luger, S; Bunse, L; Solecki, G; Eichwald, V; Jugold, M; Hodecker, S; Osswald, M; Meisner, C; Hielscher, T; Rübmann, P; Pfenning, P N; Ronellenfitsch, M; Kempf, T; Schnölzer, M; Abdollahi, A; Lang, F; Bendszus, M; von Deimling, A; Winkler, F; Weller, M; Vajkoczy, P; Platten, M; Wick, W (2014). mTOR target NDRG1 confers MGMT-dependent resistance to alkylating chemotherapy. Proceedings of the National Academy of Sciences of the United States of America, 111(1):409-414.

This list was generated on Mon Jun 24 11:33:35 2019 CEST.